Teoxane
USPTO PatentsView assignee record - 14 granted patents across 9 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations).
The verdict
According to USPTO PatentsView, Teoxane ranks #20,504 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 9 technology areas.
- #20,504
- of 49,997 US assignees by volume
- 44th percentile
- by Innovation Score (33.4/100)
- 16.9
- avg claims per patent
- -73%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R20504 · Foreign Corporation #20,504 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 14 grants
- MID-PACK #20,504/49,997
- PHOTO-FINISH TBM
- CPC-NARROW A61Q · 9 areas
- INNOV-THIN 33.4/100
- CLAIMS-RICH 16.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -73% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: TBM Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Teoxane’s 33.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Teoxane
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Teoxane · this assignee 33
Teoxane · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Teoxane's Innovation Score is 33.4/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Teoxane?
Each dot is one of Teoxane’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Teoxane’s own 16.9 claims/patent is ABOVE the 11.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Teoxane's grants concentrate
Teoxane is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2017. By volume, Teoxane sits between TBM Co., Ltd. and Texa S.P.A..
Teoxane's three-year grant acceleration
Teoxane shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Teoxane's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- TBM
TBM Co., Ltd.
14 patents
- Technetix B V
Technetix B.V.
14 patents
- Technip Energies…
Technip Energies France
14 patents
- Techwin
Techwin Co., Ltd.
14 patents
- Tesla Laboratories
Tesla Laboratories, LLC
14 patents
- Teso LT UAB
Teso LT, UAB
14 patents
- Teva Pharmaceutic…
Teva Pharmaceuticals Australia PTY Ltd
14 patents
- Texa S P A
Texa S.P.A.
14 patents
- Teoxane ◀
Teoxane
14 patents
What this shows Teoxane holds 14 patents at rank #20,494, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Teoxane
By rank, the assignees closest to #20,494 in granted patent volume.
- TBM Co., Ltd. #20,490 · 14 patents
- Technetix B.V. #20,491 · 14 patents
- Technip Energies France #20,492 · 14 patents
- Techwin Co., Ltd. #20,493 · 14 patents
- Tesla Laboratories, LLC #20,495 · 14 patents
- Teso LT, UAB #20,496 · 14 patents
- Teva Pharmaceuticals Australia PTY Ltd #20,497 · 14 patents
- Texa S.P.A. #20,498 · 14 patents
Leaders in A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations)
Other assignees with the most granted patents in Teoxane's primary technology class.
Teoxane's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 44th percentile higher than 44% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 28.6% |
| 2017 | 1 | 7.1% |
| 2018 | 3 | 21.4% |
| 2019 | 3 | 21.4% |
| 2020 | 1 | 7.1% |
| 2022 | 2 | 14.3% |
Which technologies does Teoxane patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Teoxane's patent record in context - here's where to go next.
- Teoxane's lead technology class is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61Q
- Ranked #20,504 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Teoxane against TBM Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.